Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin Oral Taste vs Subcutaneous Injection: Mechanism Comparison

Oral (swallowed) Peptide must survive gastric acid (pH 1.5–3.5), pepsin degradation, small intestine protease activity, and hepatic first-pass metabolism before reaching systemic circulation Effectively 0%. Complete enzymatic degradation within 10–20 minutes N

This comparison does not assign a generated winner or score.

  • Oral (swallowed)
  • Peptide must survive gastric acid (pH 1.5–3.5), pepsin degradation, small intestine protease activity, and hepatic first-pass metabolism before reaching systemic circulation
  • Effectively 0%. Complete enzymatic degradation within 10–20 minutes
  • Not viable. No detectable plasma tesamorelin levels achieved
  • Oral tesamorelin is pharmacologically impossible with current formulations. Any marketed "oral peptide" claiming GHRH activity without specialized delivery technology is either misrepresented or fraudulent.
  • Sublingual (under tongue)
  • Absorption through oral mucosa into sublingual venous plexus, bypassing first-pass metabolism
  • 2–8% maximum for unmodified peptides. Tesamorelin's molecular weight (5,136 Da) exceeds ideal range for mucosal absorption
  • Theoretically possible but impractical. Would require 12–25× higher doses than subcutaneous to achieve equivalent plasma levels
  • Sublingual peptide delivery requires formulations with permeation enhancers and pH buffers. Standard reconstituted tesamorelin lacks both. Even if held sublingually, most would be swallowed and degraded.
  • Subcutaneous injection
  • Direct delivery into subcutaneous adipose tissue, gradual absorption into capillary beds, systemic distribution via bloodstream
  • 70–85%. Peak plasma concentration reached within 30–60 minutes post-injection, half-life approximately 26–38 minutes
  • Fully viable. Standard clinical and research route
  • Subcutaneous injection is the only validated route for tesamorelin. Dose precision, predictable pharmacokinetics, and minimal first-pass degradation make it the gold standard. The 2mg daily dose is calibrated specifically for this route.
More references

Related material